Review

Published on 31 Aug 2023

Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials

in Pharmacology of Anti-Cancer Drugs

Jiahui Yu
Mengnan Li
Boxu Ren
Le Cheng
Xiaoxiao Wang
Zhaowu Ma
Wei Peng Yong
Xiaoguang Chen
Lingzhi Wang
Boon Cher Goh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261575

3,098 views
4 citations

Original Research

Published on 31 Aug 2023

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers

in Pharmacology of Anti-Cancer Drugs

Shuzhao Chen
Limei Zhang
Mayan Huang
Yang Liang
Yun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190660

2,050 views
3 citations

Case Report

Published on 31 Aug 2023

Zanubrutinib-induced aseptic meningitis: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Jinjun Yang
Lian Wang
Xiao Zhong
Chenlu Yang
Yu Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242491

2,054 views
2 citations

Systematic Review

Published on 31 Aug 2023

Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes

in Pharmacology of Anti-Cancer Drugs

Xianzhi Xu
Feng Dai
Yiting Mao
Kai Zhang
Ying Qin
Jiwei Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242488

2,553 views
6 citations

Review

Published on 30 Aug 2023

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges

in Pharmacology of Anti-Cancer Drugs

Isha Bansal
Amit Kumar Pandey
Munindra Ruwali

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244597

5,531 views
3 citations

Original Research

Published on 30 Aug 2023

CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome

in Pharmacology of Anti-Cancer Drugs

Songyi Park
Sunghye Lee
Dongyeop Kim
Hyejeong Kim
Young-Guen Kwon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242970

1,612 views
1 citation

Case Report

Published on 30 Aug 2023

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report

in Pharmacology of Anti-Cancer Drugs

Chan-Ran Park
Hye-Ri Bae
Ga-Young Lee
Chang-Gue Son
Jung-Hyo Cho
Chong-Kwan Cho
Nam-Hun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203379

1,574 views
1 citation

Case Report

Published on 29 Aug 2023

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Linlin Li
Siyuan Huang
Liying Qin
Ningning Yan
Shujing Shen
Xingya Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257592

2,250 views
2 citations

Case Report

Published on 29 Aug 2023

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Haoyue Hu
Songtao Tan
Meng Xie
Peng Guo
Qiang Yu
Juan Xiao
Kangrui Zhao
Qiong Liao
Yi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167959

3,846 views
1 citation

Review

Published on 28 Aug 2023

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

in Pharmacology of Anti-Cancer Drugs

Huimin Zhou
Cong Zhao
Rongguang Shao
Yanni Xu
Wuli Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187741

7,965 views
11 citations

Original Research

Published on 28 Aug 2023

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease

in Pharmacology of Anti-Cancer Drugs

Xiao Li
Yong-Li Gu
Xu-Chao Liu
Zeng-Xian Sun
Ying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218480

1,551 views
1 citation

Editorial

Published on 25 Aug 2023

Editorial: Adaptive immune resistance in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Aimin Jiang
Ouyang Chen
Zhigang Liu
Hongzhou Cai
Linhui Wang
Lin Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1277902

1,618 views

Original Research

Published on 24 Aug 2023

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness

in Pharmacology of Anti-Cancer Drugs

Sheng Tu
Yunqing Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1213506

1,318 views
1 citation

Original Research

Published on 24 Aug 2023

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators

in Pharmacology of Anti-Cancer Drugs

Yang Liu
Yizhao Wang
Chang Li
Huijin Feng
Yanqing Liu
Lianjun Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1254918

1,746 views
2 citations

Review

Published on 24 Aug 2023

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

in Pharmacology of Anti-Cancer Drugs

Lu Zhan
Fangting Su
Qiang Li
Yueqiang Wen
Feng Wei
Zhelin He
Xiaoyan Chen
Xiang Yin
Jian Wang
Yilin Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257450

4,902 views
4 citations

Original Research

Published on 24 Aug 2023

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system

in Pharmacology of Anti-Cancer Drugs

Qiaona Wang
Yunshou Lin
Wenguan Yu
Xiaogang Chen
Qingqing He
Zhiyu Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228052

1,778 views
1 citation

Navigation group

Articles

Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers

Zanubrutinib-induced aseptic meningitis: a case report and literature review

Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges

CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease

Editorial: Adaptive immune resistance in cancer therapy

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system